Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Working Group Report
We conclude that existing guidance documents, although they were largely developed for HETE studies, are highly useful for the broad range of non-HETE RWD analyses as well.
Authors
- Eric Barrette (ORCID: https://orcid.org/0000-0002-2611-1652)
- Rafael Alfonso‐Cristancho (ORCID: https://orcid.org/0000-0002-7060-5131)
- Jon D. Morrow (ORCID: https://orcid.org/0000-0002-3162-2756)
- Ami Buikema (ORCID: https://orcid.org/0000-0002-2481-4872)
- William H. Crown (ORCID: https://orcid.org/0000-0002-8822-2737)
- Andy Surinach (ORCID: https://orcid.org/0000-0002-0743-7219)
- Mark J. Cziraky
- Melinda Hanisch
- S. G. Sheth
- Samuel C.Z. Gautier
Institutions
- Rutgers, The State University of New Jersey (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Wilmington University (US)
- Novo Nordisk (United States) (US)
- GlaxoSmithKline (United States) (US)
- New York University (US)
Publication Details
- Journal
- Value in Health
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1016/j.jval.2025.02.017
- Citations
- 1
- Primary Topic
- Advanced Causal Inference Techniques
- Type
- article
- Field-Weighted Citation Impact
- 2.63